Company Filing History:
Years Active: 2010
Title: Innovations by Elena Afonina
Introduction
Elena Afonina is a notable inventor based in Frederick, MD (US). She has made significant contributions to the field of biotechnology, particularly in the development of antiviral therapies. Her work focuses on creating innovative solutions to combat viral infections.
Latest Patents
Elena Afonina holds a patent for "Long lasting fusion peptide inhibitors for HIV infection." This invention relates to C34 peptide derivatives that act as inhibitors of viral infection and exhibit antifusogenic properties. Specifically, her invention targets human immunodeficiency virus (HIV), respiratory syncytial virus (RSV), human parainfluenza virus (HPV), measles virus (MeV), and simian immunodeficiency virus (SIV). The C34 derivatives she developed are characterized by their long duration of action, making them promising candidates for the treatment of these viral infections.
Career Highlights
Elena Afonina is associated with Conjuchem Biotechnologies Inc., where she continues to advance her research in antiviral therapies. Her dedication to innovation in biotechnology has positioned her as a key figure in the fight against viral diseases.
Collaborations
Elena has collaborated with esteemed colleagues such as John W. Erickson and Dominique P. Bridon. These partnerships have further enhanced her research and development efforts in the field.
Conclusion
Elena Afonina's contributions to biotechnology, particularly through her patent for long-lasting fusion peptide inhibitors, highlight her commitment to addressing critical health challenges. Her work exemplifies the impact of innovative research in the fight against viral infections.